ClinicalTrials.Veeva

Menu

A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Enrolling

Conditions

Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT04108182
BIOMS-POAHF

Details and patient eligibility

About

The registry study aims to discover the prognostic value of bio-markers in acute heart failure

Enrollment

850 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Patients aged greater than or equal to 18 years with acute exacerbation of chronic heart failure or new heart failure
    1. With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling and fatigue (Limited activity endurance), increased jugular pressure, rales and peripheral edema ;
    1. Plasma concentrations of BNP: BNP>100pg/ML
    1. Echocardiography: Related structural heart disease (left ventricular hypertrophy and/or left atrial enlargement) and/or diastolic dysfunction

Exclusion criteria

    1. Previous history of cancer or renal replacement therapy
  • 2.Surgery was performed within a month
  • 3.Accompanied by cardiogenic shock, sepsis, pneumonia
  • 4.Eligible patients without informed consent form

Trial contacts and locations

1

Loading...

Central trial contact

Yulin Li, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems